19-45179774-G-T

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_212550.5(BLOC1S3):​c.478G>T​(p.Val160Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00252 in 1,543,998 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0019 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0026 ( 7 hom. )

Consequence

BLOC1S3
NM_212550.5 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:4

Conservation

PhyloP100: 2.22
Variant links:
Genes affected
BLOC1S3 (HGNC:20914): (biogenesis of lysosomal organelles complex 1 subunit 3) This gene encodes a protein that is a component of the BLOC1 multi-subunit protein complex. This complex is necessary for the biogenesis of specialized organelles of the endosomal-lysosomal system, including platelet dense granules and melanosomes. Mutations in this gene cause Hermansky-Pudlak syndrome 8, a disease characterized by lysosomal storage defects, bleeding due to platelet storage pool deficiency, and oculocutaneous albinism. [provided by RefSeq, Jul 2008]
MARK4 (HGNC:13538): (microtubule affinity regulating kinase 4) This gene encodes a member of the microtubule affinity-regulating kinase family. These protein kinases phosphorylate microtubule-associated proteins and regulate the transition between stable and dynamic microtubules. The encoded protein is associated with the centrosome throughout mitosis and may be involved in cell cycle control. Expression of this gene is a potential marker for cancer, and the encoded protein may also play a role in Alzheimer's disease. Pseudogenes of this gene are located on both the short and long arm of chromosome 3. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007274896).
BP6
Variant 19-45179774-G-T is Benign according to our data. Variant chr19-45179774-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 290104.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Uncertain_significance=2}. Variant chr19-45179774-G-T is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAdExome4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BLOC1S3NM_212550.5 linkc.478G>T p.Val160Leu missense_variant Exon 2 of 2 ENST00000433642.3 NP_997715.1 Q6QNY0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BLOC1S3ENST00000433642.3 linkc.478G>T p.Val160Leu missense_variant Exon 2 of 2 2 NM_212550.5 ENSP00000393840.1 Q6QNY0

Frequencies

GnomAD3 genomes
AF:
0.00195
AC:
296
AN:
152114
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000796
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00354
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.00281
Gnomad OTH
AF:
0.00383
GnomAD3 exomes
AF:
0.00167
AC:
245
AN:
146848
Hom.:
1
AF XY:
0.00162
AC XY:
135
AN XY:
83322
show subpopulations
Gnomad AFR exome
AF:
0.000216
Gnomad AMR exome
AF:
0.00176
Gnomad ASJ exome
AF:
0.00347
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000210
Gnomad FIN exome
AF:
0.000577
Gnomad NFE exome
AF:
0.00250
Gnomad OTH exome
AF:
0.00210
GnomAD4 exome
AF:
0.00259
AC:
3600
AN:
1391774
Hom.:
7
Cov.:
31
AF XY:
0.00253
AC XY:
1742
AN XY:
689776
show subpopulations
Gnomad4 AFR exome
AF:
0.000415
Gnomad4 AMR exome
AF:
0.00209
Gnomad4 ASJ exome
AF:
0.00350
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000211
Gnomad4 FIN exome
AF:
0.000391
Gnomad4 NFE exome
AF:
0.00297
Gnomad4 OTH exome
AF:
0.00232
GnomAD4 genome
AF:
0.00194
AC:
296
AN:
152224
Hom.:
1
Cov.:
32
AF XY:
0.00203
AC XY:
151
AN XY:
74426
show subpopulations
Gnomad4 AFR
AF:
0.000794
Gnomad4 AMR
AF:
0.00353
Gnomad4 ASJ
AF:
0.00259
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00281
Gnomad4 OTH
AF:
0.00379
Alfa
AF:
0.000648
Hom.:
0
Bravo
AF:
0.00229
ExAC
AF:
0.00121
AC:
134
Asia WGS
AF:
0.000578
AC:
2
AN:
3474

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Oct 10, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 03, 2023
Mayo Clinic Laboratories, Mayo Clinic
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

BP4, PM1 -

Inborn genetic diseases Uncertain:1
Oct 21, 2021
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.478G>T (p.V160L) alteration is located in exon 2 (coding exon 1) of the BLOC1S3 gene. This alteration results from a G to T substitution at nucleotide position 478, causing the valine (V) at amino acid position 160 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

BLOC1S3-related disorder Benign:1
Apr 08, 2021
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not specified Benign:1
Sep 20, 2016
Eurofins Ntd Llc (ga)
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.28
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.33
CADD
Benign
22
DANN
Benign
0.95
DEOGEN2
Benign
0.16
T;T;T
Eigen
Benign
-0.32
Eigen_PC
Benign
-0.23
FATHMM_MKL
Benign
0.57
D
LIST_S2
Benign
0.52
.;T;T
MetaRNN
Benign
0.0073
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.55
N;N;.
PrimateAI
Pathogenic
0.96
D
PROVEAN
Benign
-0.21
N;.;.
REVEL
Benign
0.074
Sift
Benign
0.53
T;.;.
Sift4G
Benign
0.35
T;T;T
Polyphen
0.64
P;P;.
Vest4
0.17
MutPred
0.22
Gain of disorder (P = 0.1041);Gain of disorder (P = 0.1041);.;
MVP
0.14
MPC
0.98
ClinPred
0.015
T
GERP RS
2.2
Varity_R
0.070
gMVP
0.23

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201502372; hg19: chr19-45683032; API